Santé publique et sciences de la vie

Nous travaillons avec le milieu médical à transformer la vie des patients en le dotant des meilleurs dirigeants et des meilleurs talents disponibles dans le monde entier.

Sous-sections

Fournisseurs de médicaments en vente libre, institutions de recherche privées, fabricants d'appareillages et autres acteurs du secteur des sciences de la vie profitent de l'expertise spécialisée de Boyden dans ce domaine particulier.

Kerry Moynihan

Conseiller principal, Washington D.C.

Gilbert J. Carrara, MD

Associé directeur, États-Unis
Americas Leader, Healthcare & Life Sciences Practice

Articles et publications

Europe Regional Analysis: Strengthening the human-centric core of Industry 5.0

How can organisations thrive in a complex world of risk?

Articles et publications

Strengthening the human-centric core of Industry 5.0

How can organisations thrive in a complex world of risk?

Articles et publications

ESG in Biotech: Paving the Way for a Sustainable Future

The impact of ESG investing is too significant to ignore and with the battle for funds at its peak, the biotech industry needs to be at the forefront of the agenda. With impending mandates, the pressure is firmly on businesses to start thinking about their ESG proposition and how it may positively influence and affect the wider industry.

Perspectives de l'industrie

Alphabet’s Health Goals

America’s healthcare industry is ripe for disruption, and Google parent company Alphabet is leading the charge in wearables, health records, AI and longevity.

Communiqués de presse

Boyden’s US Growth Continues with Marquee Hires Dorothy Billingsly and Keith Dorsey

Senior advisors and business academics in healthcare, professional services and corporate governance bring unique expertise to clients

This website uses cookies to ensure you get the best experience on our website. Learn more